Covered recipient · General Payments record
STEPHANIE D DAVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,271.96
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.31 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $189.48 | 6 |
| SHIELD THERAPEUTICS INC | $73.59 | 1 |
| Organon LLC | $55.44 | 3 |
| Exeltis, USA Inc. | $26.64 | 2 |
| ABBVIE INC. | $17.70 | 1 |
| Kerecis Limited | $16.33 | 1 |
| Sumitomo Pharma America, Inc. | $15.67 | 1 |
| Radius Health, Inc. | $13.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.70 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106996092 | CMS |
| Astellas Pharma US Inc | $14.32 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139493608 | CMS |
| Astellas Pharma US Inc | $15.03 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139500918 | CMS |
| Astellas Pharma US Inc | $108.64 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139523852 | CMS |
| Astellas Pharma US Inc | $17.81 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139471112 | CMS |
| Astellas Pharma US Inc | $15.14 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139479996 | CMS |
| Astellas Pharma US Inc | $18.54 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139554505 | CMS |
| Exeltis, USA Inc. | $13.51 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011071 | CMS |
| Exeltis, USA Inc. | $13.13 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150011073 | CMS |
| Kerecis Limited | $16.33 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120099204 | CMS |
| Organon Llc | $15.26 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136197220 | CMS |
| Organon Llc | $14.21 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136197222 | CMS |
| Organon Llc | $25.97 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136197224 | CMS |
| Radius Health, Inc. | $13.46 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090041958 | CMS |
| SHIELD THERAPEUTICS INC | $73.59 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150145946 | CMS |
| Sumitomo Pharma America, Inc. | $15.67 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148954828 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.